Plexus Products

The Science of Slim

A clinical study using Plexus Slim was conducted in 2008. The study was conducted with eight type 2 diabetes patients of mixed gender and age. While all patients carried excess weight to varying degrees, the primary purpose of this study was to see how well the product reduced glucose levels in Type 2 diabetics. The weight loss was a secondary consideration.

Test Period 6/5/08 to 10/31/08;        
  Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8
Beginning Weight 331 155 267 216 179 165 205 145
Weight at 30-Day Mark 317 151 262 201 173 156 202 136
End Weight 302 150 257 166 161 143 198 129
Weight Loss 29 5 10 50 18 22 7 16
                 
Beginning Avg. Glucose Level 187 129 231 159 170 150 174 169
End Avg. Glucose Level 114 81 118 85 98 95 108 116
Drop in Avg. Glucose Level 73 48 113 74 72 55 66 53
                 
Loss of inches in fatty areas? Yes Yes Yes Yes Yes Yes Yes Yes
Energy Level Improved Improved Improved Improved Improved Improved Improved Improved
Appetite Control Improved Improved Improved Improved Improved Improved Improved Improved

Study Results: All patients experienced improvement in the above listed areas and categories. Many times shedding the final 5–10 pounds of excess weight is the most difficult. It is important to note that even patients with relatively little excess weight (5–10 lbs) were able to shed these excess pounds.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any diseases.